Search

Your search keyword '"Scearce, Richard"' showing total 232 results

Search Constraints

Start Over You searched for: Author "Scearce, Richard" Remove constraint Author: "Scearce, Richard"
232 results on '"Scearce, Richard"'

Search Results

1. Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity

2. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

3. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

4. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines

5. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.

6. Immune checkpoint modulation enhances HIV-1 antibody induction

8. Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection

9. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide

10. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

11. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

13. Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved

14. Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates

17. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

18. Mouse and Human Antibodies that Bind HLA-E-Leader Peptide Complexes and Enhance NK Cell Cytotoxicity

19. RAB11FIP5-Deficient Mice Exhibit Cytokine-Related Transcriptomic Signatures

20. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

23. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

27. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

28. Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates

29. Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models

30. Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations

32. HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies

33. Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates

34. Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

35. HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism

36. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

37. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity

39. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site

40. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost

41. The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes1

45. HIV-1 Envelope gp41 Antibodies Can Originate from Terminal Ileum B Cells that Share Cross-Reactivity with Commensal Bacteria

46. Induction of HIV-1 Broad Neutralizing Antibodies in 2F5 Knock-in Mice: Selection against Membrane Proximal External Region–Associated Autoreactivity Limits T-Dependent Responses

47. Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1

48. Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41

49. Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies

50. Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens

Catalog

Books, media, physical & digital resources